Find the right fit for you - faster
Get tailored insights about working at Acino in one quick step.
Acino Snapshot
We are driven by our collective purpose to improve patients' lives in emerging markets.
Internally: we're dynamic and responsive but also approachable and accountable. We work together as one team and celebrate the practical problem solvers, the ones who see a solution and get it done.
In B2C: we proudly stand for consistently high-quality products for all. This means patients in emerging markets have access to high-quality products where and where they need them most.
In B2B: we pride ourselves on building close, long-lasting relationships, working hand-in-hand with our partners in global and local markets. We take a proactive approach to find win-win solutions that never compromise on quality and integrity.
Internally: we're dynamic and responsive but also approachable and accountable. We work together as one team and celebrate the practical problem solvers, the ones who see a solution and get it done.
In B2C: we proudly stand for consistently high-quality products for all. This means patients in emerging markets have access to high-quality products where and where they need them most.
In B2B: we pride ourselves on building close, long-lasting relationships, working hand-in-hand with our partners in global and local markets. We take a proactive approach to find win-win solutions that never compromise on quality and integrity.
Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, Russia, the CIS Region, and Latin America. The company is backed by Nordic Capital and Avista Capital Partners. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets, and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information, visit www.acino.swiss.
